RT @AurelieRheumo: ORAL surveillance TOFA vs. TNFi: in patients with > 50yo > 1 CV risk MTX IR -# â¬ï¸ in MACE
Tweet Content
ORAL surveillance TOFA vs. TNFi:
in patients with > 50yo > 1 CV risk MTX IR
-# ⬆️ in MACE and MI (not stroke)
-MACE risk factors on TOFA smoking, >65 male gender
-# ⬆️ MACE in its w/ any of these RF
What are you going to tell your patients? #Abtr0958 #ACR21 #ACRBest @RheumNow https://t.co/81kVTH63bb
Show on Archive Page
On
Display in Search Results
On
PDQ
Off